We also analyzed the liver tissue of HCC patients and found that the expression of RBM17 was positively correlated with tumor size and AFP value (Fig. 2H), indicating its potential role in HCC progression and poor prognosis. The gene discussed is RBM17; the disease is hepatocellular carcinoma.